Literature DB >> 29665983

IL-1 Family Cytokine Pathways Underlying NAFLD: Towards New Treatment Strategies.

Andreea-Manuela Mirea1, Cees J Tack1, Triantafyllos Chavakis2, Leo A B Joosten1, Erik J M Toonen3.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Pathways responsible for the activation of IL-1 family cytokines are key in the development of NAFLD but underlying mechanisms are not fully understood. Many studies have focused on the inflammasome-caspase-1 pathway and have shown that this pathway is an important inducer of inflammation in NAFLD. However, this pathway is not solely responsible for the activation of proinflammatory cytokines. Also, neutrophil serine proteases (NSPs) are capable of activating cytokines and recent studies reported that these proteases also contribute to NAFLD. These studies provided, for the first time, evidence that this inflammasome-independent pathway is involved in NAFLD. In our opinion, these new insights open up new approaches for therapeutic intervention.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  inflammasome; inflammation; interleukin-1; neutrophil serine proteases; nonalcoholic fatty liver disease; obesity

Mesh:

Substances:

Year:  2018        PMID: 29665983      PMCID: PMC5939989          DOI: 10.1016/j.molmed.2018.03.005

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  66 in total

Review 1.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

2.  Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1β and by the induction of endogenous IL-1Ra.

Authors:  Leo A B Joosten; Tania O Crişan; Tania Azam; Maartje C P Cleophas; Marije I Koenders; Frank L van de Veerdonk; Mihai G Netea; Soohyun Kim; Charles A Dinarello
Journal:  Ann Rheum Dis       Date:  2015-07-14       Impact factor: 19.103

3.  Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells.

Authors:  Timea Csak; Michal Ganz; Justin Pespisa; Karen Kodys; Angela Dolganiuc; Gyongyi Szabo
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

4.  Neutrophil serine proteases promote IL-1β generation and injury in necrotizing crescentic glomerulonephritis.

Authors:  Adrian Schreiber; Christine T N Pham; Ying Hu; Wolfgang Schneider; Friedrich C Luft; Ralph Kettritz
Journal:  J Am Soc Nephrol       Date:  2012-01-12       Impact factor: 10.121

5.  Pivotal Role of TNF-α in the Development and Progression of Nonalcoholic Fatty Liver Disease in a Murine Model.

Authors:  Satomi Kakino; Tsuyoshi Ohki; Hitomi Nakayama; Xiahong Yuan; Shuichi Otabe; Toshihiko Hashinaga; Nobuhiko Wada; Yayoi Kurita; Kayo Tanaka; Kento Hara; Eri Soejima; Yuji Tajiri; Kentaro Yamada
Journal:  Horm Metab Res       Date:  2017-09-18       Impact factor: 2.936

Review 6.  The role of interleukin-18 in the metabolic syndrome.

Authors:  Marius Trøseid; Ingebjørg Seljeflot; Harald Arnesen
Journal:  Cardiovasc Diabetol       Date:  2010-03-23       Impact factor: 9.951

Review 7.  The inflammasome in liver injury and non-alcoholic fatty liver disease.

Authors:  Wajahat Zafar Mehal
Journal:  Dig Dis       Date:  2014-07-14       Impact factor: 2.404

8.  Interleukin-1 participates in the progression from liver injury to fibrosis.

Authors:  Roben G Gieling; Karen Wallace; Yuan-Ping Han
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-02       Impact factor: 4.052

9.  Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation.

Authors:  Hiroe Honda; Yoshinori Nagai; Takayuki Matsunaga; Naoki Okamoto; Yasuharu Watanabe; Koichi Tsuneyama; Hiroaki Hayashi; Isao Fujii; Masashi Ikutani; Yoshikatsu Hirai; Atsushi Muraguchi; Kiyoshi Takatsu
Journal:  J Leukoc Biol       Date:  2014-09-10       Impact factor: 4.962

10.  Erratum: A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet.

Authors:  Gabsik Yang; Hye Eun Lee; Joo Young Lee
Journal:  Sci Rep       Date:  2016-05-20       Impact factor: 4.379

View more
  31 in total

1.  Exercise suppresses NLRP3 inflammasome activation in mice with diet-induced NASH: a plausible role of adropin.

Authors:  Wenqi Yang; Ling Liu; Yuan Wei; Chunlu Fang; Shujing Liu; Fu Zhou; Yaping Li; Ge Zhao; Ziyi Guo; Yuan Luo; Liangming Li
Journal:  Lab Invest       Date:  2020-12-02       Impact factor: 5.662

Review 2.  The Role of Innate Immune Cells in Nonalcoholic Fatty Liver Disease.

Authors:  Marina Nati; Kyoung-Jin Chung; Triantafyllos Chavakis
Journal:  J Innate Immun       Date:  2021-08-24       Impact factor: 7.349

3.  Protective Roles of Shilajit in Modulating Resistin, Adiponectin, and Cytokines in Rats with Non-alcoholic Fatty Liver Disease.

Authors:  Baran Ghezelbash; Nader Shahrokhi; Mohammad Khaksari; Gholamreza Asadikaram; Maryam Shahrokhi; Sara Shirazpour
Journal:  Chin J Integr Med       Date:  2022-03-08       Impact factor: 1.978

Review 4.  Mesenchymal stem cells-based therapy in liver diseases.

Authors:  Heng-Tong Han; Wei-Lin Jin; Xun Li
Journal:  Mol Biomed       Date:  2022-07-27

5.  A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation.

Authors:  Marijana Vujkovic; Shweta Ramdas; Daniel J Rader; Benjamin F Voight; Kyong-Mi Chang; Kim M Lorenz; Xiuqing Guo; Rebecca Darlay; Heather J Cordell; Jing He; Yevgeniy Gindin; Chuhan Chung; Robert P Myers; Carolin V Schneider; Joseph Park; Kyung Min Lee; Marina Serper; Rotonya M Carr; David E Kaplan; Mary E Haas; Matthew T MacLean; Walter R Witschey; Xiang Zhu; Catherine Tcheandjieu; Rachel L Kember; Henry R Kranzler; Anurag Verma; Ayush Giri; Derek M Klarin; Yan V Sun; Jie Huang; Jennifer E Huffman; Kate Townsend Creasy; Nicholas J Hand; Ching-Ti Liu; Michelle T Long; Jie Yao; Matthew Budoff; Jingyi Tan; Xiaohui Li; Henry J Lin; Yii-Der Ida Chen; Kent D Taylor; Ruey-Kang Chang; Ronald M Krauss; Silvia Vilarinho; Joseph Brancale; Jonas B Nielsen; Adam E Locke; Marcus B Jones; Niek Verweij; Aris Baras; K Rajender Reddy; Brent A Neuschwander-Tetri; Jeffrey B Schwimmer; Arun J Sanyal; Naga Chalasani; Kathleen A Ryan; Braxton D Mitchell; Dipender Gill; Andrew D Wells; Elisabetta Manduchi; Yedidya Saiman; Nadim Mahmud; Donald R Miller; Peter D Reaven; Lawrence S Phillips; Sumitra Muralidhar; Scott L DuVall; Jennifer S Lee; Themistocles L Assimes; Saiju Pyarajan; Kelly Cho; Todd L Edwards; Scott M Damrauer; Peter W Wilson; J Michael Gaziano; Christopher J O'Donnell; Amit V Khera; Struan F A Grant; Christopher D Brown; Philip S Tsao; Danish Saleheen; Luca A Lotta; Lisa Bastarache; Quentin M Anstee; Ann K Daly; James B Meigs; Jerome I Rotter; Julie A Lynch
Journal:  Nat Genet       Date:  2022-06-02       Impact factor: 41.307

6.  Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver disease.

Authors:  Jeongeun Hyun; Muthana Al Abo; Rajesh Kumar Dutta; Seh Hoon Oh; Kun Xiang; Xiyou Zhou; Raquel Maeso-Díaz; Rebecca Caffrey; Arun J Sanyal; Jennifer A Freedman; Steven R Patierno; Cynthia A Moylan; Manal F Abdelmalek; Anna Mae Diehl
Journal:  J Hepatol       Date:  2021-05-06       Impact factor: 30.083

Review 7.  Liver macrophages and inflammation in physiology and physiopathology of non-alcoholic fatty liver disease.

Authors:  Ronan Thibaut; Matthew C Gage; Inès Pineda-Torra; Gwladys Chabrier; Nicolas Venteclef; Fawaz Alzaid
Journal:  FEBS J       Date:  2021-05-02       Impact factor: 5.622

8.  Could protein content of Urinary Extracellular Vesicles be useful to detect Cirrhosis in Alcoholic Liver Disease?

Authors:  Esperanza Gonzalez; Mikel Azkargorta; Clara Garcia-Vallicrosa; Janire Prieto-Elordui; Felix Elortza; Sonia Blanco-Sampascual; Juan Manuel Falcon-Perez
Journal:  Int J Biol Sci       Date:  2021-05-05       Impact factor: 6.580

9.  Context-Dependent IL-1 mRNA-Destabilization by TTP Prevents Dysregulation of Immune Homeostasis Under Steady State Conditions.

Authors:  Lucy Sneezum; Kevin Eislmayr; Helene Dworak; Vitaly Sedlyarov; Anita Le Heron; Florian Ebner; Irmgard Fischer; Yoichiro Iwakura; Pavel Kovarik
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

10.  Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis.

Authors:  Teresa Auguet; Laia Bertran; Jessica Binetti; Carmen Aguilar; Salomé Martínez; Fàtima Sabench; Jesús Miguel Lopez-Dupla; José Antonio Porras; David Riesco; Daniel Del Castillo; Cristóbal Richart
Journal:  Int J Mol Sci       Date:  2020-06-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.